跳至主要内容
临床试验/IRCT2017101732057N3
IRCT2017101732057N3已完成未知

The effect of Gemfibrozil for treatment of cigarette dependence

Vice chancellor for research of Kashan University of Medical Sciences and Health Services0 个研究点目标入组 76 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
76

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 years 至 65 years(—)
性别
All

入选标准

  • Having an age of 19–65 years; nicotine dependence based on DSM 5; lack of history of psychotic disorders; having negative results in opioid and amphetamines test; lacking diagnosis of chronic disease such as debate, blood pressure , cancer and etc; Not be pregnant. Exclusion criteria: Unwillingness to continue participating in the study; being pregnancy during study; uses drugs with contraindication or Interference with Gemfibrozil such as Anticoagulants, statins, other fibrates and niacin.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research of Kashan University of Medical Sciences and Health Services

相似试验